#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA798129	F	Inhibition of growth of Rift Valley fever virus in vero cells by administering 250 ug/mL of compound	Chlorocebus sabaeus	1		organism-based format	Scientific Literature
2.	ALA798130	F	Percent increase in survival rate of Rift Valley fever virus infected mice on day 21, by administering 100 (mg/kg)/day of compound	Rift Valley fever virus	1		organism-based format	Scientific Literature
3.	ALA798131	F	Percent increase in survival rate of Rift Valley fever virus infected mice on day 21, by administering 50 (mg/kg)/day of compound	Rift Valley fever virus	1		organism-based format	Scientific Literature
4.	ALA798132	F	Inhibitory activity of compound against Rift valley fever virus (RVF) was evaluated in vitro; Inactive	Rift Valley fever virus	9		organism-based format	Scientific Literature
5.	ALA798133	F	In vitro antiviral activity was tested against rift valley fever virus(RVF) virus	Rift Valley fever virus	6		organism-based format	Scientific Literature
6.	ALA879372	F	In vitro antiviral activity was tested against rift valley fever virus(RVF)	Rift Valley fever virus	1		organism-based format	Scientific Literature
7.	ALA798135	F	In vitro antiviral activity was tested against rift valley fever virus(RVF) virus	Rift Valley fever virus	1		organism-based format	Scientific Literature
8.	ALA2044324	F	Antiviral activity against Rift Valley fever virus at 5 uM	Rift Valley fever virus	2		organism-based format	Scientific Literature
9.	ALA2061800	F	Antiviral activity against Rift Valley fever virus infected in african green monkey Vero 76 cells assessed as reduction of viral replication	Rift Valley fever virus	2		organism-based format	Scientific Literature
10.	ALA1837302	F	Antiviral activity against Rift Valley fever virus assessed as inhibition of viral replication	Rift Valley fever virus	21		organism-based format	Scientific Literature
11.	ALA1011336	F	Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells after 6 days by plaque reduction assay	Rift Valley fever virus	22		organism-based format	Scientific Literature
12.	ALA986895	F	Antiviral activity against Rift Valley fever virus MP-12 assessed as inhibition of virus-induced visual cytopathic effect after 3 to 5 days	Rift Valley fever virus	2		organism-based format	Scientific Literature
13.	ALA986903	F	Antiviral activity against Rift Valley fever virus MP-12 assessed as reduction of 1 log10 unit viral titer yields after 3 to 5 days	Rift Valley fever virus	1		organism-based format	Scientific Literature
14.	ALA1012924	F	Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells assessed as plaque reduction at 250 ug/mL	Rift Valley fever virus	1		organism-based format	Scientific Literature
15.	ALA1012928	F	Antiviral activity against Rift Valley fever virus infected in mouse assessed as survival	Rift Valley fever virus	1		organism-based format	Scientific Literature
16.	ALA1024030	F	Antiviral activity against Rift Valley fever virus infected in african green monkey Vero cells assessed as plaque reduction at 0.05 ug/mL	Rift Valley fever virus	1		organism-based format	Scientific Literature
17.	ALA1112352	F	Antiviral activity against Rift Valley fever virus	Rift Valley fever virus	5		organism-based format	Scientific Literature
18.	ALA2317855	F	Antiviral activity against Rift Valley fever virus infected in african green monkey Vero 76 cells assessed as reduction of viral replication	Rift Valley fever virus	4		organism-based format	Scientific Literature
19.	ALA5255503	F	Antiviral activity against Rift Valley fever virus MP-12 infected in African green monkey Vero 76 cells by visual analysis	Rift Valley fever virus	2		organism-based format	Scientific Literature
20.	ALA5255506	F	Antiviral activity against Rift Valley fever virus MP-12 infected in African green monkey Vero 76 cells by neutral red dye based analysis	Rift Valley fever virus	2		organism-based format	Scientific Literature